Reuters logo
BRIEF-Merck KGaA partners with Array BioPharma, Pierre Fabre on mCRC phase iii trial
2016年6月4日 / 下午1点27分 / 1 年前

BRIEF-Merck KGaA partners with Array BioPharma, Pierre Fabre on mCRC phase iii trial

June 4 (Reuters) - Merck KGaA

* Says partners with Array BioPharma and Pierre Fabre to initiate braf-mutant mCRC phase iii trial Further company coverage:

我们的标准汤森路透“信任原则”
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below